Global Longlife Hospital and Research Limited (BOM:543520)
10.11
-0.39 (-3.71%)
At close: Jun 17, 2026
BOM:543520 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | - | 5.77 | 135.15 | 235.02 | 328.15 |
Other Revenue | - | 0.03 | 0.04 | 0.04 | 0.21 |
| - | 5.8 | 135.18 | 235.05 | 328.36 | |
Revenue Growth (YoY) | - | -95.71% | -42.49% | -28.42% | 0.41% |
Cost of Revenue | 1.94 | 34.25 | 118.74 | 172.21 | 214.77 |
Gross Profit | -1.94 | -28.45 | 16.45 | 62.84 | 113.59 |
Selling, General & Admin | - | 0.42 | 0.13 | 0.28 | 0.75 |
Other Operating Expenses | 7.99 | 12.5 | 18.74 | 21.85 | 29.65 |
Operating Expenses | 7.99 | 17.74 | 31.36 | 33.8 | 41.84 |
Operating Income | -9.93 | -46.19 | -14.92 | 29.05 | 71.75 |
Interest Expense | -0 | -2.92 | -7.04 | -3.2 | -15.08 |
Interest & Investment Income | - | 1.3 | 0.59 | 1.26 | 2.04 |
Other Non Operating Income (Expenses) | 0.05 | -0.03 | -0.71 | -0.03 | -1 |
EBT Excluding Unusual Items | -9.88 | -47.84 | -22.08 | 27.08 | 57.71 |
Gain (Loss) on Sale of Investments | - | 5.71 | - | - | - |
Gain (Loss) on Sale of Assets | - | 43.12 | -0.58 | - | -0.61 |
Pretax Income | -9.88 | 0.99 | -22.66 | 27.08 | 57.1 |
Income Tax Expense | 7.32 | -1 | -0.78 | 8.8 | 21.36 |
Net Income | -17.2 | 1.99 | -21.88 | 18.28 | 35.74 |
Net Income to Common | -17.2 | 1.99 | -21.88 | 18.28 | 35.74 |
Net Income Growth | - | - | - | -48.86% | 74.59% |
Shares Outstanding (Basic) | 10 | 11 | 11 | 10 | 7 |
Shares Outstanding (Diluted) | 10 | 11 | 11 | 10 | 7 |
Shares Change (YoY) | -0.14% | - | 3.11% | 45.48% | - |
EPS (Basic) | -1.64 | 0.19 | -2.08 | 1.79 | 5.11 |
EPS (Diluted) | -1.64 | 0.19 | -2.08 | 1.79 | 5.11 |
EPS Growth | - | - | - | -64.94% | 74.85% |
Free Cash Flow | -45.1 | 122.48 | -61.21 | -424.2 | 89.49 |
Free Cash Flow Per Share | -4.30 | 11.66 | -5.83 | -41.66 | 12.79 |
Gross Margin | - | - | 12.17% | 26.74% | 34.59% |
Operating Margin | - | -796.35% | -11.03% | 12.36% | 21.85% |
Profit Margin | - | 34.26% | -16.19% | 7.78% | 10.88% |
Free Cash Flow Margin | - | 2111.78% | -45.28% | -180.47% | 27.25% |
EBITDA | -5.12 | -41.38 | -2.43 | 40.71 | 83.19 |
EBITDA Margin | - | - | -1.80% | 17.32% | 25.33% |
D&A For EBITDA | 4.81 | 4.81 | 12.49 | 11.67 | 11.43 |
EBIT | -9.93 | -46.19 | -14.92 | 29.05 | 71.75 |
EBIT Margin | - | - | -11.03% | 12.36% | 21.85% |
Effective Tax Rate | - | - | - | 32.51% | 37.41% |
Revenue as Reported | 0.05 | 55.93 | 135.78 | 237.4 | 330.43 |